Assessment of cell free DNA (cfDNA) and RNA (cfRNA), circulating tumor cells (CTC) and
extracellular vesicles (EV) in blood or other bodily fluids can enable early cancer detection …

Biospecimens acquired during routine medical practice are the primary sources of molecular
information about patients and their diseases that underlies precision medicine and …

Gaps in the translation of research findings to clinical management have been recognized
for decades. They exist for the diagnosis as well as the management of cancer. The …

Background: Cancer-induced mortality is increasingly prevalent globally, which skyrocketed
the necessity to discover new/novel, safe and effective anticancer drugs. Cancer is …

The rapid expansion of modern cancer immunotherapeutics has led to a dramatic
improvement in patient survival and sustained remission for otherwise refractory …

Identifying metabolites and delineating their immune-regulatory contribution in the tumor
microenvironment is an area of intense study. Interrogating metabolites and metabolic …

Cancer is one of the most common and important diseases with a high mortality rate. Breast
cancer is among the three most common types of cancer in women, and the mortality rate …

The orbit can harbor mass lesions of various cellular origins. The symptoms vary
considerably according to the nature, location, and extent of the disease and include …

Objective The aggressive triple-negative breast cancer (TNBC) subtype disproportionately
affects women of African ancestry across the diaspora, but its frequency across Africa has …

Immune Checkpoint Inhibitors (ICIs) have remarkably modified the way solid tumors are
managed, including breast cancer. Unfortunately, only a relatively small number of breast …